Simulations Plus (SLP) Reports In-Line Q2 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. FFAI
5. FFR
6. META
7. FICO
8. CART
9. LLY
10. TSLA

Go back to Simulations Plus (SLP) Reports In-Line Q2 EPS

Simulations Plus Reports Second Quarter FY2016 Financial Results

April 13, 2016 4:01 PM EDT

Record second quarter as revenues grow 12.9%, net income up 18%

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its second quarter of fiscal year 2016, the period ended February 29, 2016 (2QFY16).

2QFY16 highlights compared with 2QFY15:

Net revenues increased 12.9%, or $590,000, to $5.16 million from $4.57 million Gross profit increased 13.3%, or $457,000, to $3.90 million from $3.44 million... More